Company: SXTPW
Filing Date: 2025-06-06
Form Type: DRS
Source: 0001213900-25-052232
Chunk: 66

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-06-06
Form: DRS
Chunk 66
---
 placement agent for each and every future public or private
offering or other capital-raising financing of equity or equity-linked securities using an underwriter or placement agent by us or
any of our successors or subsidiaries, subject to certain exceptions.

Tail

We have also agreed to
pay the placement agent a tail fee equal to the cash and warrant compensation in this offering, if any investor, who was wall-crossed
by the placement agent with respect to a non-public offering or had back and forth correspondence with the placement agent with respect
to a public offering of our securities, in each case during the term of its engagement, provides us with capital in any public or private
offering or other financing or capital raising transaction during the twelve-month period following expiration or termination
of our engagement of the placement agent, subject to an exception.

Other Relationships

From time to time, the placement agent may provide in the future, various
advisory, investment and commercial banking and other services to us in the ordinary course of business, for which it may receive customary
fees and commissions. Except as disclosed in this prospectus, we have no present arrangements with the placement agent for any further
services.

Determination of Offering Price

The combined offering
price per share and accompanying Warrants and the combined offering price per Pre-Funded Warrants and accompanying Warrants we are
offering and the exercise prices and other terms of the Warrants were negotiated between us and the investors, in consultation with the
placement agent based on the trading of our common stock prior to this offering, among other things. Other factors considered in determining
the offering prices of the securities we are offering and the exercise prices and other terms of the Warrants include the history and
prospects of our company, the stage of development of our business, our business plans for the future and the extent to which they have
been implemented, an assessment of our management, general conditions of the securities markets at the time of the offering and such other
factors as were deemed relevant.

<div align='center'>36</div>

Lock-up Agreements

We and each of our executive
officers, directors and holders of 5% or greater of our outstanding shares of common stock have agreed with the placement agent to be
subject to a lock-up period of days following the date
of closing of the offering pursuant to this prospectus. This means that, during the applicable lock-up period, we and such persons
may not offer for sale, contract to sell,